Navigation Links
Patient Safety in Challenging Economic Times is Focus of NPSF Annual Congress on May 20-22
Date:1/13/2009

BOSTON, Jan. 13 /PRNewswire/ -- Responding to the increased risk to patient safety in an economic downturn, the National Patient Safety Foundation has announced that the 2009 NPSF Patient Safety Congress will directly address this issue through an extensive program of educational sessions designed to provide attendees with the new thinking and tools critical to keeping patients safe.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080307/AQF053LOGO)

This highly acclaimed annual event, to be held May 20-22 at the Gaylord National outside Washington, DC, boasts over 35 individual sessions targeting seven core areas essential to patient safety. In addition, insightful and inspiring plenaries are planned, including a town hall meeting with authors of the pivotal Institute of Medicine report "To Err Is Human" and distinguished members of the Lucian Leape Institute. Intensive full-day pre-Congress programs will also be offered, highlighted by a unique executive-level event providing case studies and discussion focused on successfully building a safety framework, setting safety and quality priorities, and ensuring critical physician engagement. Plus, the NPSF Congress provides direct access to a wide array of innovative solutions providers.

"These times demand increased vigilance from us all," explained Diane Pinakiewicz, President of the National Patient Safety Foundation, "and, as adversity threatens, it also sparks creativity and unique problem-solving, a mindset that is at the very heart of this year's Congress."

Widely recognized as the definitive patient safety event each year, the 2009 NPSF Congress will provide the new learnings, practical tools, and innovative solutions essential to keeping patients safe during these challenging times, and will offer unparalleled opportunities for attendees to collaborate with safety experts and influential healthcare leaders.

"Now more than ever, an unwavering focus on patient safety is critical," noted Ms. Pinakiewicz. "The risks are too great to respond otherwise."

Visit http://www.npsf.org for complete program details and registration information. Attendees may also register by calling 401.766.4904.

About the National Patient Safety Foundation

The National Patient Safety Foundation is an independent not-for-profit 501(c)(3) organization that has been diligently pursuing one mission since its founding in 1997 -- to improve the safety of patients. NPSF also occupies a unique position by virtue of its inclusive, multi-stakeholder approach, which fosters collaboration on the issue of patient safety.


'/>"/>
SOURCE National Patient Safety Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
5. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
6. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
7. Cardinal Health Establishes $1 Million Grant Fund for Initiatives That Improve Quality, Safety of Patient Care
8. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
9. Stimuvax(R) Phase II data highlight three-year survival results for patients with non-small cell lung cancer
10. Spectrum Pharmaceuticals Initiates Second Registrational Phase 3 Clinical Trial for EOquin(R) in Patients With Non-Invasive Bladder Cancer
11. Ortho Biotech Supports FDA Advisory Committees Recommendations on Use of ESAs in Chronic Renal Failure Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Oct. 11, 2017  VMS BioMarketing, a leading provider of ... oncology Clinical Nurse Educator (CNE) network, which will launch this ... communication among health care professionals to enhance the patient care ... staff, and other health care professionals to help women who ... ...
(Date:10/10/2017)... ... October 10, 2017 , ... San Diego-based team building and cooking ... initiative announced today. The bold new look is part of a transformation to ... into a significant growth period. , It will also expand its service offering from ...
(Date:10/10/2017)... 10, 2017 SomaGenics announced the receipt of ... develop RealSeq®-SC (Single Cell), expected to be the first ... (including microRNAs) from single cells using NGS methods. The ... to accelerate development of approaches to analyze the heterogeneity ... "New techniques for measuring levels of mRNAs in individual ...
(Date:10/9/2017)... ... October 09, 2017 , ... At its national board ... Stubbs, a professor in Harvard University’s Departments of Physics and Astronomy, has been selected ... member of the winning team for the 2015 Breakthrough Prize in Fundamental physics for ...
Breaking Biology Technology:
(Date:10/4/2017)... , Oct. 4, 2017  GCE Solutions, a global clinical research ... and document anonymization solution on October 4, 2017. Shadow is designed ... to comply with policy 0070 of the European Medicines Agency (EMA) ... ... Solutions ...
(Date:8/15/2017)... , Aug. 15 2017   ivWatch LLC , a ... intravenous (IV) therapy, today announced receipt of its ISO 13485 Certification, ... by the International Organization for Standardization (ISO®). ... ivWatch Model 400 Continuous Monitoring device for the early ... "This is an ...
(Date:6/30/2017)... , June 30, 2017 Today, American ... and supplier of face and eye tracking software, ... Product provider program. "Artificial intelligence ... way to monitor a driver,s attentiveness levels while ... being able to detect fatigue and prevent potential ...
Breaking Biology News(10 mins):